Highlights d LincGET is asymmetrically expressed in the nucleus of twoto four-cell mouse embryos d LincGET overexpression biases blastomere fate toward inner cell mass (ICM) d LincGET physically binds to CARM1 d LincGET/CARM1 activates ICM-specific genes
INTRODUCTION
Long noncoding RNAs (lncRNAs) have recently emerged as key regulators of many important biological events (Rinn and Chang, 2012) , including controlling stem cell pluripotency and differentiation (Guttman et al., 2011; Hu et al., 2012; Ng and Stanton, 2013) . However, it remains unknown whether lncRNAs are also actively involved in the process of early embryonic cell fate decision, such as the first lineage segregation that bifurcate the totipotent zygote into the inner cell mass (ICM), which contributes to the fetus, and the trophectoderm (TE), which contributes to the placenta.
In mammalian early embryonic development, the blastomeres within an embryo are morphologically indistinguishable before the eight-cell stage, and their fates are relatively flexible depending on the regulative nature of mammalian embryo development (Rossant and Tam, 2009 ). However, recent emerging studies have provided compelling evidence that molecular heterogeneity already exists in four-to eight-cell-stage embryos, which predispose the fate of early blastomeres toward either ICM or TE (Goolam et al., 2016; Piotrowska-Nitsche et al., 2005; Plachta et al., 2011; Tabansky et al., 2013; Torres-Padilla et al., 2007; White et al., 2016) . To date, the earliest molecular heterogeneity documented was at the four-cell embryo stage. Coactivator-associated arginine methyltransferase 1 (CARM1) was first found asymmetrically distributed between four-cell blastomeres in mice; high CARM1 led to increased levels of histone H3 arginine 26 methylation (H3R26me), which biased the subsequent fate of these blastomeres toward ICM (Torres-Padilla et al., 2007) . Recent evidence further showed that high expression of CARM1 at the four-cell stage also increased the OCT4/ SOX2-DNA-bound fraction and the expression of its downstream target gene, such as Sox21 (Goolam et al., 2016; Plachta et al., 2011; White et al., 2016) . In addition, PRDM14 was found to be heterogeneously expressed in four-cell-stage embryos, and it interacted with CARM1 to promote H3R26me (Burton et al., 2013) . Together, elevation of proteins in the CARM1/PRDM14-OCT4/SOX2-SOX21 axis at the four-cell stage will bias the future progeny of blastomeres toward an ICM fate.
Despite these advances, a key question still remains as to how the observed heterogeneity at the four-cell stage arises in the first place. Is the factor responsible for such heterogeneity buried at the two-cell stage and controlled by upstream regulators? Indeed, with recent research advances using single-blastomere RNA sequencing (RNA-seq), we found that blastomere-to-blastomere heterogeneity already exists at the two-cell stage (Shi et al., 2015) . Moreover, we recently found that an endogenous retrovirus (ERV)-associated lncRNA, LincGET, was expressed along with zygotic genome activation (ZGA) and specifically persisted through the late two-to fourcell mouse embryo stage, and that LincGET was essential for embryo development . Intriguingly, when we analyzed blastomere-to-blastomere heterogeneity of LincGET expression using single-blastomere RNA-seq datasets (Deng et al., 2014) , we found that its level of expression from the late two-cell blastomere stage became unequal, and this asym-metric distribution was further enhanced in four-cell blastomeres ( Figure 1A) . These observations led to the present systematic analyses of the heterogeneity of LincGET in mouse early embryos and its role in regulating CARM1 level and function to bias the first fate of the embryonic cell. RNA-FISH 1C-qPCR B1 B2 B3 B4
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RESULTS
LincGET is Transiently Expressed and Asymmetrically Distributed in Two-to Four-Cell Blastomeres To systematically examine the spatiotemporal expression of LincGET in early mouse embryos, we performed fluorescence in situ hybridization (FISH) and quantitative PCR with TaqMan probe (TM-qPCR), targeting the LincGET-specific region (2,591-2,780 nt) ( Figure S1A ) throughout mouse early preimplantation embryo development. The TM-qPCR results reinforced our bioinformatics analysis, showing transient LincGET expression at the two-to four-cell stage (Figures S1B and S1C). Moreover, the FISH ( Figure S1D ) and northern blotting ( Figure S1E ) analyses further confirmed that LincGET expression is restricted to the nuclei, appearing first at the early two-cell stage followed by upregulation through the late two-cell to early four-cell stage, downregulation through the late four-cell to early eight-cell stage, and subsequently lack of detection at the late eight-cell stage.
Notably, we observed heterogeneous LincGET expression in two-to four-cell embryos based on fluorescence intensity and single-blastomere TM-qPCR (1C-qPCR) analyses, which was consistent with our bioinformatics analyses ( Figure 1A ). Blastomere-to-blastomere expression of LincGET was highly variable between two-cell ( Figures 1B-1E ) and four-cell blastomeres ( Figures 1F-1I ) compared to the overall equal expression of Hprt between blastomeres ( Figures 1C and 1G ). Moreover, it is notable that the extent of heterogeneous expression of LincGET in four-cell blastomeres was further increased compared to that in two-cell embryos (Figures 1C and 1G) . Together, these data raised the possibility that LincGET may play a role in directing the developmental fates of early blastomeres.
Increased LincGET Biased Blastomeres toward an ICM Fate
To test whether LincGET plays a role in biasing early blastomere fate, we overexpressed LincGET by injecting LincGET RNA into one of the two-cell blastomeres, with a co-injection of green fluo-rescent protein-Klarsicht/ANC-1/Syne-1 homology (GFP-KASH; Gfp) RNA as a lineage tracer, and then monitored embryo development to the blastocyst stage ( Figure 2A ). We documented an elevated level of LincGET by TM-qPCR at the four-to eight-cell stages after two-cell stage overexpression, yet the elevation quickly decreased by the late eight-cell stage and decreased almost down to normal levels at the 16-cell stage ( Figure 2B ). These findings suggested that the turnover of injected LincGET RNA was regulated similarly to the endogenously expressed LincGET.
To examine the function of LincGET in biasing early embryonic fate, we also performed a parallel Carm1-overexpression analysis as a positive control. This was achieved by similarly injecting Carm1 mRNA and the Gfp tracer into one of the two-cell blastomeres followed by expression validation at the four-cell stage (Figures 2C and 2D) , as previous research has demonstrated that overexpression of Carm1 in one of the two-cell blastomeres can bias embryo lineage fate (Torres-Padilla et al., 2007) . Injection of only the Gfp tracer into one of the two-cell blastomeres served as a negative control. The embryos overexpressing either LincGET or Carm1 (about 150 ng/mL) developed normally and reached the blastocyst stage and birth similar to those injected with only the Gfp tracer ( Figure 2E and Table S1 ), showing that overexpression of LincGET or Carm1 does not adversely affect embryo development.
We next analyzed the GFP-positive cell population in the resulting blastocysts from the three experimental groups (Gfp only, LincGET + Gfp, and Carm1 + Gfp). The blastocysts used for cell allocation analysis were processed for cortical F-actin staining to show membrane boundaries (Torres-Padilla et al., 2007) such that the contribution of GFP-labeled cells to the inner (ICM) or outer (TE) layer of the blastocyst could be distinguished and analyzed ( Figure 2E ). As shown in Figure 2E , the total number of cells in blastocysts and the percentage of GFPpositive cells were similar among different groups. However, the percentage of GFP-positive cells in the ICM was significantly higher in the LincGET + Gfp (85.15% ± 9.17%) and Carm1 + Gfp Figure 2 . Increased LincGET Biased Blastomeres toward an ICM Fate (A) Schematic overview. RNA (Gfp, Carm1 + Gfp, or LincGET + Gfp) was injected into one blastomere of late two-cell embryos, and the distributions of GFPpositive cells were analyzed at the blastocyst stage (1) in three dimensions to view the inner or outer patterns and (2) by SOX2 immunofluorescence (IF) for the ICM or TE pattern. Nuclear-membrane-localized GFP-KASH (Gfp) was used as a lineage tracer. (B) TM-qPCR results confirming the overexpression of LincGET. Three experimental replicates were performed. The error bars represent SEM. (C and D) Western blot (C) and IF (D) results confirming the overexpression of CARM1. Three experimental replicates were performed. OE, overexpression; a-, anti-. Scale bar, 50 mm. (E) Analysis of the distribution of progeny of injected blastomere at the blastocyst stage based on 3D reconstruction. Data were represented as mean ± SEM. Two-tailed Student's t tests were used for statistical analysis. Different letters (between x and y) indicate very significant differences (p < 0.00001). Key to table headings: blastocyst 3D (%) is the number and developmental rate of blastocysts that were all used for the 3D analysis, total cells (n) is the total number of cells in the blastocyst, inner cells (%) is the percentage of inner cells out of the total number of cells in the blastocyst, GFP cells (%) is the percentage of GFP-positive cells out of the total number of cells in the blastocyst, GFP cells that are inner (%) is the percentage of GFP-positive inner cells out of the total number of GFP-positive cells in the blastocyst, inner cells that are GFP + (%) is the percentage of GFP-positive inner cells out of the total number of inner cells in the blastocyst, and GFP cells that are inner (%) is the percentage of GFP-positive inner cells out of the total number of total cells in the blastocyst. Figure S2C . About 40% of GFPpositive cells were SOX2-positive in the control group, while the percentage was about 80% for the Carm1 + Gfp and LincGET + GFP groups. Two-tailed Student's t tests were used for statistical analysis. Different letters (between x and y) indicate very significant differences (p < 0.00001). See also Figure S2 , and Tables S1, S2, and S3. Table S2 ). Moreover, we examined the expression of SOX2 as an ICM marker in the blastocysts from the three groups and found that the percentage of SOX2-positive cells at the blastocyst stage was much higher in GFP-positive cells derived from both the LincGET + Gfp (84.22% ± 14.45%) and Carm1 + Gfp (74.63% ± 15.05%) groups than the Gfp only (43.57% ± 11.39%) group ( Figures 2H and S2C and Table S3 ). These results demonstrated that forced overexpression of LincGET in one of the two-cell blastomeres biased its progeny cells toward an ICM fate. In order to exclude the possibility that the phenotypic observations may be caused by the large amounts of synthetic RNA being injected, we injected a set of controls: Dyei, another mouse ERV-associated lncRNA that has been identified from the genome locus near LincGET (between Dyrk1b and Eid2 on chromosome 7) and expressed at the two-to four-cell stages ; pancIl17d, a promoter-associated nocoding RNA with interleukin-17d, which is expressed at the two-to four-cell stages and promotes the expression of interleukin-17d from the four-cell stage (Hamazaki et al., 2015) ; 1-2,570 nt of LincGET; 3,940-6,285 nt of LincGET; and antisense of ampicillin restriction gene (antiAmpR). We found that all of these controls have no effect on preimplantation development, as blastocyst rate and GFP-positive cell rate were normal, and none of the controls could bias fate ( Figure S3 ).
Knockdown of LincGET Expression Prevents Blastomeres from Undergoing an ICM Fate
On the other hand, we wondered whether LincGET knockdown could prevent blastomeres from undergoing an ICM fate. Our previous study showed that near-complete depletion of Linc-GET in single-cell embryos resulted in a two-cell-stage arrest , suggesting LincGET played an essential role in early embryo development. Thus, to study how LincGET knockdown affected cell fate, we performed a knockdown titration assay. The knockdown reagent locked nucleic acid (LNA) was injected into single blastomeres of two-cell embryos at different concentrations followed by analysis of the effect on embryo development. LincGET LNA injection into single blastomeres of two-cell embryos at 10 mM, 5 mM, or 2 mM resulted in more than 94% deletion of LincGET, and nearly all injected blastomeres exhibited two-cell-stage developmental arrest (Figures 3A and 3B) . Besides, LincGET LNA injection at 1 mM depleted about 85.5% of total LincGET, and 44% of injected blastomeres could still develop to the blastocyst stage while others arrested at the two-cell stage ( Figures 3A and 3B ). Moreover, injection of LincGET LNA at 0.5 mM was unable to knock down LincGET efficiently and had little effect on preimplantation development of injected blastomeres ( Figures 3A and 3B) .
We therefore analyzed the fate choice in the blastocysts after injection of 1 mM LincGET LNA into single blastomeres at the two-cell stage. The ratio of progeny with an ICM fate was significantly reduced when the blastomeres were injected with the LincGET LNA compared with blastomeres without injection or injected with the control LNA, indicating that a lower level of LincGET prevented blastomeres undergoing an ICM fate (Figures 3C and 3D) . Furthermore, we found that these blastocysts had a lower percentage of GFP-positive cells (Figures 3C and 3D) , indicating that lower levels of LincGET do harm preimplantation development.
LincGET and CARM1 Form a Complex By performing co-localization of LincGET via FISH and CARM1 via immunofluorescence staining (IF combined with FISH [IF-coFISH]), we found that in most of the examined early four-cell embryos (eight out of nine), the nuclear intensity of LincGET and CARM1 were positively correlated ( Figures 4A, 4B , and S4). Moreover, we found that the signals of LincGET and CARM1 largely overlapped in the nuclei of early four-cell blastomeres, and more CARM1 located to the nucleus where LincGET is higher ( Figures 4A and S4 ). These data raised the possibility that LincGET may physically interact with CARM1 to form a functional complex and promote CARM1 nuclear location. We also injected Dyei into single-cell embryos (1-2 pL, 150 ng/mL, because its level is very low in four-cell embryos) and performed IF-coFISH at the four-cell stage as a staining control. The results show that Dyei does not co-localize with CARM1 ( Figure S5 ).
We separated four-cell embryos into cytoplasmic and nuclear fractions, one blastomere of which was injected with LincGET + Gfp, Gfp only, or Dyei + Gfp at two-cell stage, and evaluated CARM1 protein level by western blotting. The results showed that LincGET, but not Dyei or Gfp overexpression increased the nuclear percentage of CARM1 ( Figure 4C ). We Figure 3 . Knockdown of LincGET Expression Prevents Blastomeres from Undergoing an ICM Fate (A) Titration study to knock down LincGET using LNA at different concentrations. The TM-qPCR results showed that LNA injection at 10 mM, 5 mM, or 2 mM resulted in more than 94% deletion of LincGET; LNA injection at 1 mM and 0.5 mM resulted in depletion of 85.5% and 35% of total LincGET level, respectively. Three experimental replicates were performed. The error bars represent SEM. (B) Preimplantation developmental rate upon LincGET knockdown by LNA injection in one blastomere at the two-cell stage. Nearly all the injected blastomeres were arrested at the two-cell stage when injected with LincGET LNA at 10 mM, 5 mM, or 2 mM; 44% of blastomeres injected with LincGET LNA at 1 mM could develop to blastocyst stage; and LincGET LNA injection at 0.5 mM had no effect on preimplantation development of injected blastomeres. (C) Analysis of the distribution of progeny of injected blastomeres at the blastocyst stage based on 3D reconstruction. LNA for LincGET was at 1 mM. Data are shown as mean ± SEM. Two-tailed Student's t tests were used for statistical analysis. Different letters (between x and y) indicate very significant differences (p < 0.00001). Key to table headings: blastocyst 3D (%) is the number and developmental rate of blastocysts that were all used for 3D analysis, total cells is the total number of cells in the blastocyst, inner cells (%) is the percentage of inner cells out of the total number of cells in the blastocyst, GFP cells (%) is the percentage of GFP-positive cells out of the total number of cells in the blastocyst, GFP cells that are inner (%) is the percentage of GFP-positive inner cells out of the total number of GFP-positive cells in the blastocyst, and inner cells that are GFP + (%) is the percentage of GFP-positive inner cells out of the total number of inner cells in the blastocyst. (D) Examples of 3D analysis results. Scale bar, 50 mm. See also Table S2 . next performed RNA pull-down followed by western blotting with biotin-labeled LincGET using lysates from mESCs or early fourcell embryos ($2,600 embryos were collected for preparing the lysates for each group). The results showed that LincGET prefer to form a complex with CARM1 rather than other well-known epigenetic modifiers such as BRG1, EZH2, G9A, HDAC1, LSD1, SUZ12, and YY1 ( Figures 4D and 4E ). Moreover, we performed RNA pull-down followed by mass spectrometry using lysates from mESCs and identified 64 LincGET-specific binding proteins (anti-LincGET as control), which contain CARM1 but no other well-known epigenetic modifiers (Table S4 ). Further, we constructed a fused LincGET-MS2 RNA, whereby a minimal hairpin aptamer (named MS2) was linked to the 5 0 end of LincGET. The MS2 region of the fused LincGET-MS2 RNA could selectively bind to dimerized MS2 bacteriophage coat proteins (MS2P) (Peabody, 1993) and thus could be used for coimmunoprecipitation (coIP) experiments. The coIP experiments using mESCs expressing LincGET-MS2-fused RNAs and HAtagged MS2P showed that LincGET indeed forms an RNA-protein complex with CARM1 ( Figure 4F ). Moreover, RNA IP (RIP) of LincGET in mESCs transiently overexpressing LincGET further confirmed the LincGET-CARM1 complex ( Figure 4G ).
To further identify the functional domain of LincGET that interacts with CARM1, we generated a series of truncated LincGET RNAs marked with MS2 ( Figure 4H ) followed by coIP and RIP assays with CARM1. Our data demonstrated that fragments of nucleotides 1,301-2,570 and 3,351-4,530 of LincGET were essential for binding to CARM1 ( Figure 4H ).
We next examined the protein site in CARM1 that interacts with LincGET. We constructed four 3 3 FLAG-tagged truncated CARM1 mutants with deletion of the pleckstrin homology (PH)like domain (D PH), methyltransferase (MTase) domain (D MTase), part of the protein arginine methyltransferase (PRMT) domain (D PP), or trans-activation domain (D transA), respectively. We then performed the RIP assays using mouse epiblast stem cells (mEpiSCs) overexpressing full-length LincGET and each of the truncated CARM1 mutants. The results show that the transA domain of CARM1 is essential for LincGET binding ( Figure 4I ).
LincGET/CARM1 Complex Promoted H3R26me2 and Activated ICM Gene Expression
We further examined whether expression of LincGET in an early embryo could promote the known events downstream of CARM1, such as the establishment of H3R26me (Torres-Padilla et al., 2007) and expression of genes that promote/represent an ICM fate, such as Sox2 (Torres-Padilla et al., 2007) , Nanog (Torres-Padilla et al., 2007) , and Sox21 (Goolam et al., 2016) ( Figure 5A ). Our results showed that overexpression of Carm1 or LincGET similarly enhanced H3R26me2 levels at the eightcell stage ( Figure 5B ) and increased Nanog, Sox2, and Sox21 at both RNA and protein levels ( Figures 5C-5F ). In addition, we found that CDX2 expression at the eight-cell stage was inhibited upon Carm1 or LincGET overexpression ( Figure 5G ). Notably, the expression level of Oct4 was not significantly influenced by overexpression of Carm1 or LincGET ( Figure S6A ). The overall elevated levels of ICM-specific genes in the progeny of LincGET-/Carm1-overexpressing blastomeres is consistent with and could explain the effect of the LincGET/Carm1 complex in biasing blastomere fate toward ICM.
Given the complex feedback/feedforward nature of ICM fate/ pluripotency network, we wonder whether those ICM-specific pluripotent factors overexpression, such as Nanog, might also induce LincGET expression. As a result, we found Carm1 overexpression, but not Nanog overexpression, would induce LincGET expression ( Figure S6B ).
LincGET/CARM1 Complex Increased Global Chromatin Accessibility
We next explored the potential mechanisms by which the LincGET/CARM1 complex activates ICM-specific genes at the (C) CARM1 fractionation analysis showed LincGET overexpression, but not Dyei or Gfp overexpression, increased the percentage of nuclear CARM1. The four-cell embryos, one blastomere of which was injected with LincGET/Gfp or Gfp only at the two-cell stage, were separated into cytoplasmic and nuclear fractions. The CARM1 protein level of each fraction was evaluated by western blotting. More than 400 four-cell embryos were used for each replicate, and three experimental replicates were performed. Isoform abundance on SDS-PAGE gels was measured in ImageJ. Three experimental replicates were performed. The error bars represent SEM. Two-tailed Student's t tests were used for statistical analysis. (D) RNA pull-down-western blotting using biotinylated LincGET or antisense-LincGET (a-LincGET) with mESCs lysates (left) shows that LincGET interacts with CARM1. Three experimental replicates were performed. Two-tailed Student's t tests were used for statistical analysis. a-, anti-. (E) RNA pull-down western blotting using biotinylated LincGET or antisense-LincGET (a-LincGET) with early four-cell-stage embryo (about 2,600 embryos were used for each experiment) lysates. Three experimental replicates were performed. a-, anti-. (F) CoIP results using mEpiSCs expressing HA-MS2P with MS2-labeled LincGET or antisense-LincGET (a-LincGET) and anti-HA antibody. The results show that LincGET forms an RNA-protein complex with CARM1. Three experimental replicates were performed. a-, anti-. (G) RIP assays with LincGET-expressing mEpiSCs showing that LincGET can bind to CARM1. Three experimental replicates were performed. a-, anti-. (H) CoIP followed by RT-PCR or western blot using mEpiSCs expressing HA-MS2P with MS2-labeled LincGET mutants. The results show that the LincGET mutants with 1,301-1,950-nt, 1,951-2,570-nt, 3,351-3,940-nt, or 3,941-4,530-nt deletions could not bind CARM1, while other mutants could. Three experimental replicates were performed. 10.0 p = 0.441 p = 1.61e-27 p = 1.43e-34 p = 0.683 p = 2.24e-6 p = 7.70e-4 p = 0.357 p = 1.96e-20 p = 6.53e-24 GFP + GFPn = 7 n = 9 n = 10 n = 7 n = 8 n = 7 n = 7 n = 9 n = 10 eight-cell stage and hypothesized that this may result from altered chromatin accessibility at the promoter regions of these genes. To test this hypothesis, we examined chromatin accessibility by preforming an assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) . The results showed that the promoters of ICM-specific genes (1,168 genes) were more open in LincGET-or Carm1-overexpressing blastomeres at the eightcell stage. On the contrary, the chromatin of TE-specific gene (757 genes) promoter regions was less open compared to in control blastomeres ( Figure 6A ). There is a progressive decrease in chromatin openness along with preimplantation development, which is thought to be important for the transition from totipotency to pluripotency (Bo skovi c et al., 2014) . Therefore, we speculated the function of LincGET/ CARM1 complex in biasing ICM fate might be associated with increasing global chromatin accessibility. To examine chromatin accessibility at the single-cell level, we resorted to an imagingbased in situ DNase I-terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL) assay , where the fluorescence intensity observed in TUNEL represents a direct measurement of DNase I sensitivity, and thus chromatin accessibility ( Figure 6B ). As a result, LincGET or CARM1 overexpression similarly led to significantly higher levels of TUNEL fluorescence in the daughter cells of the overexpressed rather than the control blastomeres (Figure 6C) . Notably, we did not detect differences in levels of phosphorylated histone H2A.X between the daughter cells of the overexpressed and control blastomeres ( Figure 6C ), suggesting that the observed increase in DNase I sensitivity was not a result of DNA damage. We also compared nuclear volume, another parameter for chromatin openness , and observed a significant increase in nuclear volume after LincGET/CARM1 overexpression compared to control blastomeres ( Figure 6C) .
We have reported that LincGET prefers to activate genes locating close to long terminal repeats (LTRs) in GLN, MERVL, and ERVK (GLKLTRs) , and it has been reported that transcriptional activation of transposons such as LINE-1 in early embryos could increase global chromatin accessibility and embryonic pluripotency . It therefore raised a possibility that LincGET/CARM1-mediating ICM-specific genes activation may be linked with transposons activation and global chromatin plasticity. To this end, we indeed found that genomic LINE and LTR sequences are in closer distance to ICM-rather than TE-specific genes ( Figure 6D ). Besides, the qPCR results indeed showed that overexpression of LincGET or Carm1 in one of the two-cell blastomeres increased the expression level of transposons, including GLN, ERVL, ERVK, and LINE-1 in progeny cells at the eight-cell stage ( Figure 6E ).
Together, these converging pieces of evidence strongly suggest that LincGET and CARM1 bias the blastomeres toward an ICM fate by increasing chromatin openness and activating ICM-specific genes. How the chromatin openness induced by LincGET/ CARM1 favors gene promoters related to ICM rather than TE remains unclear, but it seems that the LincGET/CARM1 complex activates transposons and spreads the active chromatin status toward ICM-specific genes, which prefer to locate near transposons.
Interdependence of LincGET and CARM1 in Directing ICM fate Because LincGET could potentially interact with multiple proteins in addition to CARM1, we next examined whether CARM1 was the necessary protein partner that enabled LincGET to exert its function regarding the biasing of embryonic fate. By simultaneous overexpression of LincGET and depletion of Carm1 using LNA ( Figures S7A and S7B) in one of the two-cell blastomeres, we found that once Carm1 was knocked down, even if the level of LincGET was elevated, the progeny blastomeres were no longer biased toward ICM but rather tended to generate TE ( Figures 7A,  7B , S7C, and S7D). Correspondingly, depleting Carm1 in the LincGET-overexpressing blastomeres no longer upregulated the expression of Sox2, Nanog, and Sox21, and, in fact, the H3R26me2 level was decreased ( Figures 7C, S7E, and S7F) . Also, depleting Carm1 in the LincGET-overexpressing blastomeres was associated with decreased DNase I sensitivity and nuclear volume ( Figures 7D, S7G, and S7H ), suggesting that the chromatin state became more condensed. These data demonstrated that the function of LincGET in biasing embryonic fate requires the presence of CARM1.
To further test whether LincGET must interact with CARM1 as a complex to exert its function, we next injected truncated LincGET without CARM1-binding sites (nucleotides 1,301-2,570 [DC-D] or 3,351-4,530 [DF-G]) into one of the two-cell blastomeres with or without knocking down Carm1. Compared to the injection of intact LincGET, the truncated LincGET failed to upregulate Sox2 and Sox21 in the progeny blastomeres even in the presence of CARM1 (Figure 7E, red) . Besides, the intact LincGET could not Figure 5 . LincGET/CARM1 Complex Promoted H3R26me and Activated ICM Gene Expression (A) Schematic overview. RNA (Gfp, Carm1 + Gfp, or LincGET + Gfp) was injected into one blastomere of late two-cell embryos, and the levesl of H3R26me2, Nanog, Sox2, Sox21, Cdx2, and Oct4 were tested at eight-cell stage. (B) H3R26me2 staining of eight-cell embryos shows that Carm1 or LincGET overexpression led to a dramatic increase in H3R26me2 modification. For fluorescence analysis, the green ball stands for GFP + cells, and the gray ball stands for GFP À cells. Three experimental replicates were performed. Scale bar, 50 mm. Two-tailed Student's t tests were used for statistical analysis. (C-F) NANOG (C), SOX2 (E), and SOX21 (F) were increased in the progeny of Carm1-or LincGET-injected blastomeres at both the RNA (D) and protein levels. The group names in (F) are the same as in (B); the group names in (G) are the same as in (C). Three experimental replicates were performed. Scale bar, 50 mm. The error bars represent SEM. For fluorescence analysis, the green ball stands for GFP + cells and the gray ball stands for GFP À cells. Two-tailed Student's t tests were used for statistical analysis. Compared to the Gfp group, **p < 0.001, *0.01 < p < 0.05 (not significant [NS]), p > 0.05. (G) No change in CDX2 was found in the progeny of Carm1-or LincGET-injected blastomeres. Interestingly, CDX2 was detected in only some blastomeres (blastomeres showing no CDX2 expression are marked with white arrowheads). Three experimental replicates were performed. Scale bar, 50 mm. For fluorescence analysis, the green ball stands for GFP + cells, and the gray ball stands for GFP À cells. Two-tailed Student's t tests were used for statistical analysis. See also Figure S6. upregulate either Sox2 or Sox21 when Carm1 was depleted (Figures 7E and 7F, orange) . These results indicated the functional necessity of the LincGET-CARM1 complex.
In addition, we found that depletion of LincGET led to late twocell-stage arrest (10 mM LNA with nearly 100% interference efficiency), which could not be rescued by Carm1 overexpression (Figure S7I ), suggesting that LincGET is a master regulator up- Nuclear diameter n = 10 n = 10 n = 10 p = 0.787 p = 4.31e-3 p = 5.95e-3 GFP + GFPp = 0.981 p = 3.86e-8 p = 2.64e-5
Carm1 Gfp
LincGET Gfp Gfp (C) LincGET or CARM1 overexpression led to significantly higher levels of TUNEL fluorescence and increased nuclear volume in daughter cells of injected blastomeres. Scale bar, 50 mm. Three experimental replicates were performed. For fluorescence analysis, the green ball stands for GFP + cells, and the gray ball stands for GFP À cells. Two-tailed Student's t tests were used for statistical analysis.
(D) Bioinformatic analysis revealed that genomic LINE or LTR sequences are in closer distance to ICMspecific genes rather than TE-specific genes. in early-stage embryos led to binding to CARM1 but failed to upregulate Sox2 and Sox21 (Figure 7F, green) . This suggested that these truncated regions harbor important functional domains. By overexpressing both CARM1 and these LincGET mutants, we found that the truncated LincGET mutants exerted a dominant-negative effect in cancelling CARM1's function regarding upregulating Sox2 and Sox21 (Figure 7G , green). We propose that these functional domains of LincGET might be acting as ''anchors'' to guide the LincGET-CARM1 complex to its correct location in the nucleus, without which CARM1 could not function normally event if the LincGET-CARM1 complex was formed ( Figure 7H ).
DISCUSSION
The mechanisms of early mammalian cell fate determination remain to be elucidated due to the multiple layers of regulation. It remains debatable whether early blastomeres are equal in their developmental fate until the 16-cell stage or whether certain developmental bias already exists before the eight-cell stage, which predisposes early blastomeres toward either an ICM or a TE fate (Wennekamp et al., 2013; Zernicka-Goetz et al., 2009) . Recent research advances have documented the molecular differences between early mammalian blastomeres as early as the four-cell stage. Epigenetic/genetic regulators such as CARM1/PRDM14, H3R26 methylation, DNA-binding dynamics of SOX2 or OCT4, and the level of SOX21 have shown heterogeneity between four-cell blastomeres to bias cell fate (Goolam et al., 2016; Piotrowska-Nitsche et al., 2005; Plachta et al., 2011; Tabansky et al., 2013; Torres-Padilla et al., 2007; White et al., 2016) . However, the origin of the molecular heterogeneity observed at the four-cell stage remains an unresolved issue. Our data provide further evidence that the heterogeneous expression of LincGET at the late two-cell stage could act as an upstream regulator to influence subsequent lineage fate. In fact, although two-cell blastomeres are generally considered to be totipotent, there are previous pieces of evidence and recent emerging reports showing that when two-cell blastomeres are separated, in the majority of cases, only one of the two-cell blastomeres develops into a mouse (Casser et al., 2017; Katayama et al., 2010; Morris et al., 2012; Papaioannou and Ebert, 1995; Tsunoda and McLaren, 1983) . These data demonstrate inequality in the totipotency of two-cell blastomeres. Thus, our data regarding the heterogeneity of LincGET and its function in biasing lineage fate provide a molecular explanation for those experimental observations. The expression level of LincGET at the early two-cell embryo stage is almost absent, but it increases robustly at the late two-cell stage and shows heterogeneous expression between two-cell blastomeres (Figures 1 and S1 ). This suggests that the observed heterogeneity at the late two-cell embryo stage is generated de novo and thus may represent the gene expression noise that inevitably rises during ZGA, as previously reported (Shi et al., 2015) . Alternatively, the heterogeneity of LincGET at the late two-cell stage may be triggered by unequally distributed unknown factors that already existed in the early two-cell embryos.
Early cleavage embryos are known to harbor many active ERVs, yet little is known about their functions Peaston et al., 2004) . It has been reported that MERVL transcription is a unique marker of two-cell mouse embryos and two-cell-like mESCs, which have higher pluripotency than that of normal mESCs (Macfarlan et al., 2012) . In addition, embryonic chromatin at the two-cell stage has high core-histone mobility, and embryonic chromatin becomes progressively more compacted, losing plasticity and decreased developmental potency from totipotency to pluripotency (Bo skovi c et al., 2014; Jachowicz et al., 2017) . Active ERVs at the cleavage stage may have key roles in establishing totipotency to prepare materials for both TE and ICM lineage determination. There are numerous copies of ERV in the genome, which may provide an advantage for global chromatin opening. LincGET is a GLN-, MERVL-, and ERVK-associated lincRNA, and we found that increased LincGET expression enables ICM-specific gene promoters to become more open ( Figure 6A ). The origin of LincGET remains unknown, yet it raises the possibility that there might be other lncRNAs that are heavily associated with transposable elements that play important roles in early embryo development.
In addition, we further propose that differential ERV activation resulting from ZGA may generate asymmetric patterns between two blastomeres, similar to LincGET, and thus may provide an additional resource for biasing embryonic fate.
As a recently identified lncRNA, we previously revealed the role of LincGET in controlling alternative splicing (Wang et al., Figure 7 . Interdependence of LincGET and CARM1 in Directing ICM Fate (A) The distribution of progeny of injected blastomere at the blastocyst stage based on 3D reconstruction analysis. Two-tailed Student's t tests were used for statistical analysis. Different letters between x and y indicate very significant differences (p < 0.00001). Key to table headings: blastocyst 3D (%) is the number and developmental rate of blastocysts that were all used for 3D analysis, total cells is the total number of cells in the blastocyst, inner cells (%) is the percentage of inner cells out of the total number of cells in the blastocyst, GFP cells (%) is the percentage of GFP-positive cells out of the total number of cells in the blastocyst, GFP cells that are inner (%) is the percentage of GFP-positive inner cells out of the total number of GFP-positive cells in the blastocyst, and inner cells that are GFP + (%) is the percentage of GFP-positive inner cells out of the total number of inner cells in the blastocyst. (B) Examples of 3D analysis results. Scale bar, 50 mm.
(C) H3R26me2 staining shows that interference with Carm1 could reduce H3R26me2 levels even in the presence of LincGET overexpression. Three experimental replicates were performed. For fluorescence analysis, the green ball stands for GFP + cells, and the gray ball stands for GFP À cells. Two-tailed Student's t tests were used for statistical analysis. Scale bar, 50 mm. (D) TUNEL fluorescent assay shows significantly lower levels of TUNEL fluorescence in daughter cells of LincGET-overexpressing and Carm1-depleted blastomeres. Three experimental replicates were performed. For fluorescence analysis, the green ball stands for GFP + cells, and the gray ball stands for GFP À cells. Two-tailed Student's t tests were used for statistical analysis. Scale bar, 50 mm. Figure S7 and Table S2. 2016). In addition to this mechanism, here, we further found that LincGET could upregulate Sox2 and Sox21 by forming a complex with CARM1, mostly in the nucleus. This supported the idea that in addition to the expression level, the intracellular location of the RNA/protein is essential in exerting proper functions. LncRNAs have emerged as key components of intracellular scaffolds that allow proper assembly of protein complexes, genes, and chromosomes subject to proper activation and deactivation (Batista and Chang, 2013) . Intriguingly, another well-characterized lncRNA, Neat1, is also associated with transposable elements and is essential for the formation of a specific nuclear body structure called paraspeckle (Clemson et al., 2009; Lin et al., 2018) . LincGET may function in a similar fashion to Neat1 in terms of forming a scaffold and an ''address code'' for recruiting diffusible CARM1 and other essential proteins in the nucleus. Truncated LincGET (D2, 350 [DE] or D 5, 710 [DI] ) could bind to CARM1 but failed to activate CARM1 target gene expression, and this may be due to the disruption of the scaffold region of LincGET that is essential for anchoring the complex to the correct intranuclear ''address.''
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EXPERIMENTAL MODEL AND SUBJECT DETAILS

Mouse embryos collection
All experiments were performed in accordance with ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines and regulations. All of the animal experiments were performed under the ethical guidelines of the Institute of Zoology, Chinese Academy of Sciences. Procedures using animals were approved by the Institutional Animal Care and Use Committee of Institute of Zoology, Chinese Academy of Sciences. Two-cell stage embryos were collected from 6-week-old super-ovulated female ICR mice crossed with ICR males, 46 hours after the injection of human chorionic gonadotropin (hCG). One blastomere was injected with RNAs shown in Figure 2A at random.
Culture Cells
Mouse ESCs were cultured on a feeder layer in N2B27 medium supplemented with 2i (1 mM PD0325901 and 3 mM CHIR99021) and 20 ng/mL leukemia inhibitory factor (LIF). The mouse epiblast stem cells (mEpiSCs) was cultured in fibronectin coated dish in N2B27 medium plus 12 ng/mL bFGF (R&D, 233-FB-001MG/CF) and 10 ng/mL Activin A (R&D, 338-AC-01M) as described previously (Shuai et al., 2015) . The culture medium was changed every day, and the mEpiSCs was digested to single cells by 0.05% trypsin/EDTA (GIBCO, 25300062) and passaged every 2 to 3 days. For cell transfection, the mEpiSCs line was passaged and seeded at a density of 1-1.5 3 10 4 cells/cm 2 , after 2 days (60%-70% confluency), plasmid DNA (MS2-LincGET and MS2P-P65-HSF1) was transfected into cells using Lipofectamine 3000 transfection reagent (GIBCO, L3000015) according to the manufacturer's instructions. After transfection for 36 hours, cells were collected for further analysis.
METHOD DETAILS
RT-qPCR and 1C-qPCR RNA was extracted using the RNeasy Mini Kit (QIAGEN, 74104) (Invitrogen, 4458237) . All of these kits were used in accordance with the manufacturer's guidelines.
Plasmid vectors construction
In order to create Alexa Fluor 488-labeled RNA probes, the specific LincGET region (2,574-2,763), the specific Dyei region (384 -642), and part of the Egfp sequence (362-668) as a control, were amplified using LongAmpTM Taq DNA Polymerase (NEB, M0534L). These sequences were sub-cloned into the plasmid pEASY-T3 cloning vector (TransGen, CT301-02), which contains the T7 promoter. For co-IP experiments involving the MS2 coat protein (MS2P), MS2-labeled LincGET and HA-labeled MS2P were cloned into the PB533A vector (SBI, PB533A-2) digested with EcoRI or SalI, respectively. Carm1 (NM_021531 & NM_153141) overexpression vectors with CMV and T7 promoters and FLAG tag were bought from YouBio (YouBio, G156971 & G156972) and mixed equally. GFP-KASH sequence with T7 promoter for in vitro transcription was synthesized by BGI company and subcloned into pUC57 vector. LincGET and Carm1 mutants were generated by PCR, 5 0 -phosphorylation, and ligation.
CARM1 fractionation
Four-cell stage embryos (about 500 embryos for each experiment) were lysed in 50 mL of lysis buffer (10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl2 and 0.15% NP-40) for 10 min on ice. Immediately after lysis, samples were then centrifuge at 300 g at 4 C for 5 min. The supernatant was the cytoplasmic fraction and the precipitate was the nuclear fraction.
Micro-injection
We isolated 2-cell embryos from superovulated ICR female mice mated with normal males at 36 hours post-human chorionic gonadotropin (hCG) injection, and microinjected about 1-2 pL RNA at 150 ng/mL concentration into the nucleus of one blastomere of the 2-cell embryos, using an Eppendorf micromanipulator on a Nikon inverted microscope. The RNAs were in vitro transcribed with the mMESSAGE mMACHINEâ T7 ULTRA Kit (Ambion, AMB1345-5), and the DNA templates with T7 promoter were amplified using LongAmpTM Taq DNA Polymerase (NEB, M0534L). Primers are shown in Table S5 . PCR templates were plasmids shown in the KEY RESOURCES TABLE, except that for pancIl17d where the template was the mouse genome DNA. When LNA was used in co-injection, 10 mM LNA for Carm1 and 10 or 1 mM LNA for LincGET were used.
RNA pull-down
LincGET was in vitro transcribed with the mMESSAGE mMACHINE T7 ULTRA Kit (Ambion, AMB1345-5) and biotinylated with the Pierce RNA 3 0 End Desthiobiotinylation Kit (Pierce, 20163) in accordance with the manufacturer's guidelines. A slot blot was then performed to demonstrate that RNAs had been efficiently biotinylated. Fifty picomoles of biotinylated RNA was heated to 85 C for 2 min, placed immediately on ice for at least 2 min and an equal volume of RNA structure buffer (10 mM Tris pH 7.0, 0.1 M KCl, 10 mM MgCl 2 ) was added. The samples were then moved to room temperature (RT) for at least 20 min to allow appropriate secondary structure formation. Mouse embryonic stem cells (mESCs), or early 4-cell stage embryos (approximately 2,600 embryos were used for each experiment) were digested with the Pierce IP Lysis Buffer (Pierce, 87787), supplied with Protease Inhibitor Cocktail (Pierce, 78441), and used in accordance with the manufacturer's protocols. RNA-pull down was then performed using the Pierce Magnetic RNA-Protein Pull-Down Kit (Pierce, 20164) according to the manufacturer's protocol. The retrieved protein was then detected by western blotting or Mass spectrometry.
Western blotting
The protein retrieved by RNA pull-down assay, or from 200 single blastomeres from 2-cell stage embryos digested with Pierce IP Lysis Buffer (10 mL/lane), were mixed with 30 mL of sample buffer (10 mL; 1.25 mL 0.5 M-pH 6.8-Tris-HCl, 2.5 mL glycerin, 2 mL 10% SDS, 200 mL 0.5% bromophenol blue, 3.55 mL H 2 O and 0.5 mL b-mercaptoethanol) and incubated for 5 min in boiling water. The samples were then separated by SDS-PAGE with a 5% stacking gel (10 mL; 5.7 mL ddH 2 O, 2.5 mL 1.5M pH 6.8 Tris-HCl, 1.7 mL 30% acrylamide (acryl:bis acryl = 29:1), 100 mL of 10% SDS, 50 mL of 10% ammonium persulfate and 10 mL of TEMED) and a 10% separating gel (10 mL; 4.1 mL ddH 2 O, 2.5 mL 1.5M pH 8.8 Tris-HCl, 3.3 mL 30% acrylamide (acryl:bis acryl = 29:1), 100 mL of 10% SDS, 50 mL of 10% ammonium persulfate and 5 mL of TEMED) at 100 V for 1 hour. Separated proteins were then electrophoretically transferred onto a nitrocellulose membrane at 200 mA for 1 hour at 4 C. Membranes were then blocked in TBST buffer (10 mM Tris, 150 mM NaCl, 0.1% Tween 20, pH 7.4) containing 3% BSA (Sigma, B2064), for 1 hour at RT and then incubated with primary antibody, diluted in TBST containing 1% BSA, overnight at 4 C. After three washes for 10 min each in TBST, membranes were incubated for 1 hour at RT with the fluorescence secondary antibody diluted in TBST. After three washes for 10 min each, the fluorescence signals were quantified using Odyssey software.
Mass spectrometry
Mass spectrometry analysis was performed by BGI Company. Bound proteins were resolved by SDS-PAGE. The section of SDS-PAGE gel containing the protein sample was cut from gels, washed twice with 25 mM NH 4 HCO 3 and 50% acetonitrile (1 hour each time), and dehydrated by the addition of 500 mL acetonitrile. Disulfide bonds were cleaved for spots by incubating the samples for 60 min at 56 C with 200 mL of 10 mM DTT in 25 mM NH 4 HCO 3 buffer, and alkylation of cysteines was performed by the addition of 200 mL of 55 mM iodoacetamide in 25 mM NH 4 HCO 3 buffer and incubating the samples for 45 min at room temperature in darkness. The spots were then dehydrated again with 500 mL acetonitrile after washing twice with 25 mM NH 4 HCO 3 . Trypsin (Promega) solution (10 ng/mL in 25 mM NH 4 HCO 3 buffer) was then added for 37 C overnight digestion which was stopped by the addition of 5% formic acid. Finally, the extracts were dried under the protection of N 2 . Samples were reconstituted in 3 mL of 0.1% trifluoroacetic acid (TFA) prior to MS analysis. LC-ESI-MS/MS analyses were based on Orbitrap. After protein digestion, each peptide sample was desalted using a Strata X column (Phenomenex), vacuum-dried and then resuspended in a 200 mL volume of buffer A (2% Acetonitrile, 0.1% Formic acid). After centrifugation at 20,000 g for 10 min, the supernatant was recovered to obtain a peptide solution with a final concentration of approximately 0.5 mg/ml. Ten-microlitres of supernatant were loaded on a LC-20AD nanoHPLC (Shimadzu, Kyoto, Japan) by the autosampler onto a 2 cm C18 trap column. The peptides were then eluted onto a 10 cm analytical C18 column (inner diameter 75 mm) packed in-house. The samples were loaded at 8 mL/min for 4 min, then the 44 min gradient was run at 300 nL/min starting from 2 to 35% B (98% Acetonitrile, 0.1% Formic acid), followed by a 2-min linear gradient to 80%, and maintenance at 80% B for 4 min, finally returning to 5% in 1 min.
The peptides were subjected to nanoelectrospray ionization followed by tandem mass spectrometry (MS/MS) in a LTQ Orbitrap Velos (Thermo) coupled online to the HPLC. Intact peptides were detected in the Orbitrap at a resolution of 60,000. Peptides were selected for MS/MS using collision induced dissociation (CID) operating mode with a normalized collision energy setting of 35%. Ion fragments were detected in the LTQ. A data-dependent procedure that alternated between one MS scan followed by 10 MS/MS scans was applied for the 10 most abundant precursor ions above a threshold ion count of 5,000 in the MS survey scan with the following Dynamic Exclusion settings: repeat counts, 2; repeat duration, 30 s; and exclusion duration, 120 s. The applied electrospray voltage was 1.5 kV. Automatic gain control (AGC) was used to prevent overfilling of the ion trap; 1 3 10 4 ions were accumulated in the ion trap to generate CID spectra. For MS scans, the m/z scan range was 350 to 2,000 Da.
Immunoprecipitation
Magnetic Beads Protein G were coated with 5 mg of primary antibody in RIP wash buffer (50 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, 1 mM MgCl 2 , and 0.05% NP-40) containing 5% BSA overnight with rotation at 4 C. Then, we collected approximately 1 3 10 6 mESCs expressing HA-MS2P, with or without MS2-LincGET, and added 100 mL of RIP lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 0.5 mM DTT, 1 mM PMSF/cocktail) and 10 mL of RNase inhibitor (Ambion, AM2694) followed by incubation on ice for 10 min. Next, we centrifuged the RIP lysate at 14,000 rpm for 10 min at 4 C, removed 100 mL of the supernatant and added this to 900 mL of beads-antibody complex in RIP Immunoprecipitation Buffer (860 mL RIP wash buffer, 35 mL 0.5 M EDTA, and 5 mL RNase inhibitor), and incubated this with rotation overnight at 4 C. The residual 10 mL of the supernatant of RIP lysate was treated as input. After washing, the immunoprecipitate were divided into two, one part was mixed with 15 mL of western blotting sample buffer and incubated for 5 min in boiling water; this blot was used to detect CARM1 and HA-MS2P. The other part was treated with proteinase K at 55 C for 30 min with shaking to digest the protein, followed by RNA extraction from the supernatant; RT-PCR was then performed to detect LincGET.
Northern blotting
Total RNAs in 500 embryos of each stage from 1-to 8-cell were extracted using the RNeasy Mini Kit (QIAGEN, 74104) and the RNase-Free DNase Set (QIAGEN, 79254) was used to ensure that there was no DNA contamination. Total RNAs were run on 15% urea-PAGE gels (15 mL; 7.2 g Urea, 1.5 mL 10 3 TBE, 5.6 mL 40% acrylamide (acryl:bis acryl = 19:1), 75 mL 10% ammonium persulfate, and 15 mL TEMED) at 45 mA for 1 hour. The gels were then soaked for 5 min in a 0.5-1 mg/mL solution of ethidium bromide in 1 3 TBE, and visualized using a UV transilluminator. After staining, RNAs were transferred to a nylon membrane (Life) by electroblotting at 200 mA for at least 1 hour. After blotting, the RNAs were crosslinked to the membranes using a commercial UV-crosslinking device (120 mJ burst over 30 s). We then pre-hybridized the membrane in 10 mL pre-hybridization solution (6 3 SSC (Sigma), 10 3 Denhardt's solution (Invitrogen), 0.2% SDS) for at least 1 hour at 65 C. Next, we hybridized the membrane in 10 mL hybridization solution (6 3 SSC, 5 3 Denhardt's solution, 0.2% SDS) containing 0.1 mM 3 0 end-DIG-labeled single strand DNA oligonucleotide (Table S5 , BGI company) for 16 hours with gentle agitation at room temperature (RT). The membrane was then washed three times with 10 mL wash solution (6 3 SSC, 0.2% SDS) with gentle agitation at RT for 5 min, and washed once at 42 C for 10 min. After the final wash, signals were detected using the DIG detection kit (Roche, #11093657910) according to the manufacturer's protocol.
Immunofluorescence staining
Mouse embryos were fixed in 4% PFA for 30 min at RT, followed by permeabilization in normal permeabilizing solution overnight at 4 C. Embryos were then blocked in blocking solution (1% BSA in 1 3 PBS) for 1 hour at RT after 3 washes for 5 min each in washing solution (0.1% Tween-20, 0.01% Triton X-100 in 1 3 PBS), followed by incubation with primary antibody diluted with blocking solution overnight at 4 C. After 3 washes for 5 min each in washing solution, embryos were incubated with Alexa series fluorescent tag-conjugated secondary antibody diluted with washing solution for 1 hour at RT. After 3 washes in washing solution, nuclei were stained with DAPI (10 mg/mL in 1 3 PBS) for 7 min. Imaging of Embryos in microdroplet in a dish were then performed directly after 3 washes, using laser-scanning inverted confocal microscope (LSM 780). specific genes were reanalyzed from the published single cell RNA-Seq data in the GEO database GEO: GSE70605 .
To examine the transcript level of LincGET during mouse early embryo development, unique sequence from LincGET were identified by masking repeat elements, using cross_match engine in Repeat Masker (http://www.repeatmasker.org). The expression levels of LincGET during early embryo development ( Figure S1B ) was then calculated by Bowtie2 using published single-cell embryo RNA-seq datasets (GSE45719) (Deng et al., 2014) . The levels of Hprt transcript were extracted from the same dataset. The blastomere-to-blastomere heterogeneity level of LincGET and Hprt in early-, middle-, late-2-cell embryos and in 4-cell embryos ( Figure 1A) were analyzed based on their transcript level in each early blastomere using algorithm from previous publication (Shi et al., 2015) .
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses [mean ± standard error of the mean (SEM)] for differential gene expression were performed in R. Levels of significance ( Figures 1C, 1D, 1G , 1H, 2E, 2H, 3C, 4C, 5B-5G, 6C, 6E, 7A, 7C-7G, S3A, S6A, S6B, and S7E-S7H) were calculated with two tailed Student's t test. The correlation coefficient (r) and p value in Figure 4B are determined by Pearson's correlation. Two-sample Kolmogorov-Smirnov tests were used for statistical analysis in Figure 6D . Isoform abundance on SDS-PAGE gels ( Figure 4C ) was measured in ImageJ. For nuclear fluorescence intensity analysis ( Figures 1D, 1H , 4A, 5B, 5C, 5F, 5G, 6C, 7C, 7D, S4, S6A, and S7F), nuclear regions for factor signal and DNA signal were separately cut out, discolored, inverted, and lined in one picture using Photoshop, then analyzed by ImageJ, and finally the ratio ( 3 100) of factor signal intensity to DNA signal intensity was used. For SOX2 fluorescence intensity analysis which localized in both cytoplasm and nucleus at 8-cell stage (Figure 5E ), regions with same area for SOX2 signal and GFP signal were cut out, discolored, inverted, and lined in one picture using Photoshop, then analyzed by ImageJ, and finally the ratio ( 3 100) of SOX2 signal intensity to GFP signal intensity was used. In all figures: *, p value < 0.01; **, p value < 0.001 ( Figures 5D and 6E) ; different letters between x and y (Figures 2E, 2H , 3C, and 7A), p value < 0.00001; different letters among a, b, c ( Figures 7E-7G ), p value < 0.01; NS ( Figures 5D and S7E) , p value > 0.05.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the ATAC-seq data reported in this paper is NCBI GEO: GSE110419. The original data of this paper has been uploaded onto Mendeley with the link as https://doi.org/10.17632/vc5tv49rdf.1. IF combine with FISH results show co-localization of LincGET and CARM1 in the nucleus of 4-cell embryos with linear correlation. We used the relative intensity of LincGET/CARM1 (Green/Red) to nucleus DNA (Blue) as the final intensity for comparison, which could reduce errors caused by nucleus's depth between blastomeres. Scale bar, 10 mm.
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